Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Kreher

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Critical Reviews in Oncology/Hematology|November 19, 2018
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactionsHanno Riess, Paolo Prandoni, Sebastian Harder, et al.
European Journal of Haematology|March 12, 2014
R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphomaStephan Kreher, Felicitas Lammer, Dieter Augustin, et al.
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
European Journal of Immunology|February 17, 2007
Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3Hyun-Dong Chang, Christina Helbig, Lars Tykocinski, et al.
Journal of Neuro-Oncology|June 14, 2016
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphomaFelicitas Strehlow, Sandra Bauer, Peter Martus, et al.
Blood|August 8, 2008
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alphaBjörn Lamprecht, Stephan Kreher, Ioannis Anagnostopoulos, et al.
Annals of Hematology|October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
Neuro-Oncology|March 31, 2015
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphomaStephan Kreher, Korinna Jöhrens, Felicitas Strehlow, et al.
Leukemia & Lymphoma|February 14, 2013
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphomaStephanie Sasse, Achim Rothe, Helen Goergen, et al.
Annals of Hematology|September 14, 2014
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trialStephan Kreher, Felicitas Strehlow, Peter Martus, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|November 19, 2018
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactionsHanno Riess, Paolo Prandoni, Sebastian Harder, et al.
European Journal of Haematology|March 12, 2014
R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphomaStephan Kreher, Felicitas Lammer, Dieter Augustin, et al.
Deutsches Arzteblatt International|March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous ThromboembolismJan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
European Journal of Immunology|February 17, 2007
Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3Hyun-Dong Chang, Christina Helbig, Lars Tykocinski, et al.
Journal of Neuro-Oncology|June 14, 2016
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphomaFelicitas Strehlow, Sandra Bauer, Peter Martus, et al.
Blood|August 8, 2008
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alphaBjörn Lamprecht, Stephan Kreher, Ioannis Anagnostopoulos, et al.
Annals of Hematology|October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
Neuro-Oncology|March 31, 2015
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphomaStephan Kreher, Korinna Jöhrens, Felicitas Strehlow, et al.
Leukemia & Lymphoma|February 14, 2013
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphomaStephanie Sasse, Achim Rothe, Helen Goergen, et al.
Annals of Hematology|September 14, 2014
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trialStephan Kreher, Felicitas Strehlow, Peter Martus, et al.
Pageof 3